Johanna C Sierra Selected Research

Johanna C Sierra Research Topics

Disease

8	Carcinogenesis 01/2022 - 06/2006
7	Infections 01/2022 - 05/2005
5	Inflammation (Inflammations) 01/2022 - 05/2008
4	Neoplasms (Cancer) 01/2021 - 07/2009
4	Stomach Neoplasms (Stomach Cancer) 01/2020 - 06/2006
3	Colitis 01/2022 - 01/2018
3	Carcinoma (Carcinomatosis) 01/2021 - 07/2009
2	Gastritis 01/2022 - 01/2021
1	Dysbiosis 01/2022
1	Adenocarcinoma 01/2022
1	Ulcerative Colitis 01/2022
1	Metaplasia 01/2021
1	Genomic Instability 12/2019
1	Plague (Bubonic Plague) 02/2013

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2005
4	PolyaminesIBA 01/2022 - 01/2018
3	SpermidineIBA 01/2022 - 01/2018
3	Polyamine OxidaseIBA 01/2022 - 01/2018
3	Dextran SulfateIBA 01/2022 - 01/2018
3	CytokinesIBA 01/2019 - 06/2006
2	AzoxymethaneIBA 01/2022 - 01/2021
2	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2022 - 12/2019
2	Insulin (Novolin)FDA Link 01/2021 - 01/2018
2	GastrinsIBA 01/2021 - 01/2018
2	Type IV Secretion SystemsIBA 01/2017 - 07/2013
2	Virulence Factors (Pathogenicity Factors)IBA 07/2013 - 01/2013
2	Immunoglobulin M (IgM)IBA 09/2006 - 08/2006
2	CaspasesIBA 09/2006 - 08/2006
1	DefensinsIBA 01/2022
1	OrnithineIBA 01/2022
1	PutrescineIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	DNA AdductsIBA 01/2021
1	isolevuglandinIBA 01/2021
1	SpermineIBA 01/2020
1	CateninsIBA 01/2020
1	DNA Repair EnzymesIBA 12/2019
1	EnzymesIBA 12/2019
1	Eflornithine (Ornidyl)FDA Link 12/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Gefitinib (Iressa)FDA Link 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	VaccinesIBA 02/2013
1	AntibodiesIBA 02/2013
1	Recombinant ProteinsIBA 02/2013
1	Levofloxacin (Levaquin)FDA Link 02/2013
1	Cytotoxins (Cytolysins)IBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	ElementsIBA 01/2013
1	Factor V (Coagulation Factor V)IBA 01/2013
1	Type VI Secretion SystemsIBA 12/2010
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2010
1	Interleukin-10 (Interleukin 10)IBA 12/2010
1	ClusterinIBA 07/2009
1	Cisplatin (Platino)FDA LinkGeneric 07/2009
1	NF-kappa B (NF-kB)IBA 05/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008
1	phospholipase A2-activating proteinIBA 05/2008
1	Macrophage Migration-Inhibitory FactorsIBA 06/2006

Therapy/Procedure

1	Chemoprevention 01/2021
1	Ligation 09/2006